A team of researchers including scientists from the American Museum of Natural History and Scripps Institution of Oceanography at University of California San Diego found that catsharks are not only able to see the bright green biofluorescence they produce, but that they increase the contrast of their glowing pattern when deep underwater.
Grant Jordan and Paul Wicks (M.S. ’14) are former students in the Master's program in Computer Science and Engineering at the University of California San Diego. In 2015, they co-created a security-related company called SkySafe to protect organizations from illegal or dangerous incursions from commercial drones and their owners. Now, one of the top venture-capital firms in Silicon Valley, Andreessen Horowitz, has agreed to lead a $3 million investment in the fledgling company.
An outline for a new tree of life, depicting the evolution of life on this planet that included more than 1,000 new types of bacteria and Archaea lurking in the Earth’s nooks and crannies, was made possible with the help of supercomputing resources and a phylogenetics “gateway” created at the San Diego Supercomputer Center (SDSC), based at the University of California San Diego.
The Sustainable Power and Energy Center (SPEC) at the University of California San Diego recently held a Research Summit for interested industry partners. Attendees from a variety of industry sectors gathered at UC San Diego to interact with faculty and graduate students, tour the UC San Diego microgrid and attend the Jacobs School’s Research Expo in the afternoon.
Solar cells that are stretchable, flexible and wearable won the day and the best poster award from a pool of 215 at Research Expo 2016 April 14 at the University of California San Diego. The winning nanoengineering researchers aim to manufacture small, flexible devices that can power watches, LEDs and wearable sensors. The ultimate goal is to design and build much bigger flexible solar cells that could be used as power sources and shelter in natural disasters and other emergencies.
Compared to the nicotine patch and a placebo, the smoking cessation aids varenicline (marketed as Chantix in the U.S.) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events, reports an international team of researchers in a study published online April 22 in the journal The Lancet.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
